A groundbreaking global study just changed everything we thought we knew about weight loss drugs like Ozempic and Wegovy. Researchers have discovered that semaglutide, the active ingredient in these jabs, can significantly reduce the risk of heart attacks and strokes — even if you don’t lose much weight.
With over 17,000 patients across 41 countries, this is the largest and longest trial of its kind. The findings show that waist size matters more than total weight lost, and two-thirds of the heart health benefit remains unexplained by weight loss alone.
Experts now believe Ozempic is not just a weight-loss tool — it may be a life-saving treatment for heart disease and other aging-related conditions.
Is this the beginning of a new era in preventive medicine? Watch now to find out WooGlobe Ref : WGA761468 For licensing and to use this video, please email licensing@wooglobe.com
Be the first to comment